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Controlling  for socioeconomic  and  geographic  factors,  under-5  mortality  (5q0)  in developing  countries
has  been  declining  at about  2.7%  per  year,  a high  rate  of ‘technical  progress’.  This  paper  adduces  the-
oretical  and empirical  reasons  for rejecting  the  usual  speciﬁcation  of  homogeneous  technical  progress
across  countries  and  uses  a panel  of 95  developing  countries  for  the  period  1970–2000  to  explore  the
consequences  of heterogeneity.  Allowing  country-speciﬁc  rates  of  technical  progress  sharply  reduces  the
estimated  income  elasticity  of 5q0 and points  to country  variation  in  technical  progress  as the  principal
source  of  the  (large)  cross-country  variation  in 5q0  decline.  Education  levels  and  physician  coverage  also
contribute  and are  less  affected  than  income  of allowing  country  variation  in  technical  progress.  The
paper  concludes  by decomposing  1970–2000  5q0 decline  into  its different  sources  for  each  country.arying coefﬁcients model
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“The rapidity with which the death rate has declined in most
of the underdeveloped areas . . . has been unprecedented. It has
never been matched at any time in the now advanced countries
. . . it seems clear that the great reduction of mortality in under-
developed areas since 1940 has been brought about mainly by
the discovery of new methods of disease treatment applicable at
reasonable cost [and] by the diffusion of these new methods. . .
The reduction could be rapid because it did not depend on
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Though in the literature on public health there is still great lip
service paid to the necessity of general economic improvement
and community welfare in the control of disease, the truth is
that many scourges can be stamped out with none of this. . .”.
(Davis, 1956)
1. Introduction
The 20th century differed dramatically from previous history in
two critically important domains. First, the rapid economic growth
that had begun in the 19th century in the countries of the North
Atlantic diffused widely around the globe while continuing in the
countries where it originated (Maddison, 1999; DeLong, 2000). Sec-
ond, human mortality rates plummeted. Again, the changes began
in the North Atlantic countries in the 19th century but remained
modest until the 20th, during which they accelerated and spread
to most of the world (Easterlin, 1996, 1999). Life expectancies typi-
cally doubled, entailing major immediate improvements in human
welfare, dramatic declines in fertility and, in consequence, trans-
formations of the age structures of populations and their economic
environment.
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Subsequent to Solow’s (1957) assessment of the long-term
eterminants of income growth in the US, investigators have gen-
rated a huge literature on both proximate and deeper-seated
eterminants of economic growth and on the sources of its varia-
ion across countries. Far less attention has been paid to the causes
f the mortality transformation, perhaps because its magnitude and
apidity remain less widely known—or are judged less important.
et, arguably the welfare signiﬁcance of mortality reduction at least
atches that of income growth, and understanding its sources is
orrespondingly imperative.1
Most analysts agree that advances in science and technol-
gy underpinned the 20th century transformations of income
nd mortality levels. Models of economic growth rely heavily on
echnological progress (deﬁned as changes in total factor pro-
uctivity) to account for economic growth (Solow, 1957; Boskin
nd Lau, 2000; Easterly and Levine, 2003). Preston (1975, 1980)
nd Fuchs (1974) provided early quantitative assessments of
he central importance of technical progress for life expectancy
ncreases, something anticipated in the Kingsley Davis quote with
hich this paper begins. While life expectancy and per capita
ncome correlate across countries at any given time, particularly
t low income levels, Preston stressed how much average life
xpectancy has been increasing over time at any given level of
ncome. Some recent econometric works, however, attribute sub-
tantial explanatory power to income variations (see Pritchett and
ummers, 1996; Filmer and Pritchett, 1999). Yet many middle-
ncome countries today have life expectancies above 75 years with
er capita income levels close to what the US had had around
900, when US life expectancy was only about 49 years. This
imple fact supports a deeper investigation of technical progress
n health.
In this context, technical progress is more than just changes in
he sophistication of drugs, devices and techniques of medicine.
t includes improvements in public health provision and private
ealth practices which affect the adoption of the best techniques.2
ecent research has either given little emphasis to technical
rogress—in part simply because much of the research is cross-
ectional and therefore ignores developments over time—or it
as assumed the rate of technical progress to be constant across
ountries. But countries differ in how close their health systems
ome to utilizing the best technology or practice available: the
atch-up with the technical frontier may  be country-speciﬁc. Our
urpose in this paper is to model and measure this heterogeneity
xplicitly.
After introducing our data sources, we explore country-speciﬁc
echnical progress in the decline of under-5 mortality rates or 5q0
the number of deaths before the ﬁfth birthday per thousand live
irths). To facilitate estimation, we replace previously used OLS
r ﬁxed effects models with hierarchical (or multilevel, varying-
ffects) models. These models are next used to assess possible
1 Easterlin (1996) and Crafts (2000) placed an emphasis on mortality transforma-
ion that is comparable to their emphasis on economic growth in their retrospectives
n the unprecedented changes in the human condition during the 20th century,
hereas DeLong (2000), for example, places far more exclusive emphasis on the
rowth of income (and on the availability of altogether new material goods). When
easonable estimates of the dollar value of mortality reduction are added to the value
f  material output growth, however, 20–50% of the growth in total economic wel-
are has been attributed to mortality reductions for different countries in different
ras. Usher (1973) provided the ﬁrst such estimates; Mokyr and Stein (1997) pro-
ided estimates for high-income countries in the late 19th and early 20th century;
ordhaus (2003) provided recent estimates for the US; and Jamison et al. (2013)
oncluded mortality decline’s annual value in low- and middle-income countries to
ave been worth over 1% of GNI in the period 1990–2011.
2 Adams et al. (2003) used micro-data to more closely study the causal path
etween socio-economic variables and improved health. Cutler et al. (2006) pro-
ided an excellent recent review of the determinants of health. Economics 48 (2016) 16–25 17
correlates of rapid technical progress in mortality decline at the
country level. The paper then decomposes improvements in 5q0
into its country-speciﬁc constituents, including both country-level
determinants explored in previous research and the country-
speciﬁc rate of technical progress and its determinants.
2. Data
Our data set contains observations for 95 low- and middle-
income countries for up to seven ﬁve-year intervals between 1970
and 2004. A variable value for a speciﬁed year is the average for
that country of the data available for that and the following 4 years
(so GDP in 2000 is the average of GDP from 2000 to 2004). Eighty-
seven countries have data on all the variables in our models and we
use only these for some of our results. The countries are listed in
Web appendix Table D1. The main variables we  use are described
in Table 1.
We  obtain our 5q0 measure from Rajaratnam et al. (2010).3 The
income variable is real gross domestic product (GDP) per capita in
2000 international dollars from the Penn World Tables (Heston and
Summers, 1996; Summers and Heston, 1991), with some missing
data interpolated.4 The educational measure is the average number
of years of schooling for women  aged between 25 and 34 (Lutz et al.,
2007). We  also use the number of physicians per 100,000 people,
taken from the United Nations (1950–2009) as collected in Banks
(2010).
We use a set of geographical and policy variables constructed by
Harvard University’s Center for International Development to gen-
erate improved models of the determinants of economic growth
rates, in order to see if they also predict country-speciﬁc rates of
mortality decline. Gallup et al. (1999) measure the percentage of
a country’s population living in the geographical tropics (our vari-
able TROPICS) and within 100 km of a coast or navigable waterway
(COASTAL). Economic openness (OPENNESS) is the (time-invariant)
percentage of years between 1965 and 2003 that the country’s
economy was considered open estimated in Wacziarg and Welch
(2007), which builds on similar work by Sachs and Warner (1995).
We also include a health policy measure as a potential determinant
of technical progress. The coverage of a child’s third immunization
with the diphtheria, pertussis, and tetanus vaccine (DPT3) in 1986
(Lim et al., 2008) provided a natural indicator of the extent to which
a country’s health services are early adopters of powerful mortality
reducing technologies.
Table 1 shows that between 1970 and 2000 per capita income
and the average female education level both roughly doubled.
The average 5q0 was 143 in 1970 and 62 in 2000. The mean
decline across all countries over that period was 3.4% per annum.
It should be noted that the cross-country variation in the rate of
5q0 decline is itself quantitatively important. Fig. 1 displays its
distribution. As the histogram shows, there is a dramatic spread
across countries. Eight countries reduced 5q0 by less than 0.5% per
year, while 11 countries had an annual rate of reduction greater
than the 4.3% required to meet Millennium Development Goal 4
(MDG-4), which is to reduce 5q0 by two-thirds between 1990 and
2015.
3 The correlation coefﬁcients by year between this series, from UNICEF (2009) and
from the 1999 World Development Indicators range from 0.994 to 0.998 depending
on  the year (authors’ calculations). Hill and Amouzou (2006) provided a thoughtful
discussion of the difﬁculties in measuring 5q0, and how those can be addressed.
4 In Web  appendix A we test our model using different data sets for income (mea-
sured both by PPP and by the “Atlas Method”), education, physicians per capita,
and country samples and ﬁnd our results to be consistent across these choices of
variables.
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Table 1
Variables in the analysis: deﬁnitions, means and standard deviations .
Variable Deﬁnition All Years 1970 1985 2000
GDPPC GDP per capita in 1990 international dollars, Penn 3141 2346 2881 4096
World Tables (Heston et al., 2009) (2680) (2075) (2267) (3493)
lnGDPPC Natural logarithm of GDPPC 7.697 7.451 7.632 7.935
(0.87) (0.79) (0.86) (0.93)
5q0 Under-5 death rate or probability of dying prior to 5th 97.87 142.9 99.21 62.2
birthday (per 1000 live births), Rajaratnam et al. (2010) (75.32) (82.42) (72.37) (52.66)
ln5q0 Natural logarithm of 5q0 4.221 4.794 4.285 3.643
(0.93) (0.66) (0.86) (1.00)
EDFEMALE Average number of years of education in females aged
25–34, Lutz et al. (2007)
5.58 3.424 5.32 7.465
(3.31) (2.59) (2.98) (3.18)
DOCSPC Number of Physicians per 100,000 people—United
Nations (1970–2004) and Banks (2010)
874.9 435.4 678.1 1341
(1119) (534) (820) (1331)
lnDOCSPC Natural logarithm of
DOCSPC
5.842 5.282 5.651 6.483
(1.52) (1.40) (1.50) (1.38)
TROPICS Fraction of population living in the geographical Tropics,
Gallup et al. (1999)
0.391 0.359 0.348 0.444
(0.47) (0.47) (0.46) (0.48)
COASTAL Fraction of population living within 100 km of the coast,
Gallup et al. (1999)
0.474 0.490 0.471 0.480
(0.37) (0.37) (0.37) (0.38)
OPENNESS Fraction of years during 1965-2003 economy is open, Sachs
and Warner (1995) and Wacziarg and Welch (2007)
0.324 0.347 0.334 0.304
(0.29) (0.30) (0.30) (0.29)
DPT3-86 DPT3 Vaccination Coverage in 1986, Lim et al. (2008) 0.656 0.644 0.644 0.674
(0.20) (0.21) (0.21) (0.19)
Number of Observations 
Note: Entries in the table are the means for the indicated time periods with the standard 
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where, TIME is the year t, other variables are deﬁned in Table 1, and
εit is a random, i.i.d., normally distributed disturbance. A commonig. 1. Rates of decline in under-5 mortality, 95 countries, 1970–2000. Note: Values
re grouped in 1% increments above and below 4.3%, the rate required to reach
DG-4.
. The importance of heterogeneous time trends
We  think that in some important sense most scientiﬁc and
echnical knowledge is globally available.5 However, we  relax the
tandard assumption that the rate of take-up or diffusion of avail-
ble technology and know-how is the same in each country. The
pirit of our approach echoes Lee et al. (1997), who in the context of
odeling economic growth allowed not only for country-speciﬁc
ffects on income levels (time-invariant ﬁxed effects), but also
or country-speciﬁc rates of productivity growth. This paper goes
eyond previous work on mortality decline by similarly modeling
ifferent rates of technical progress across countries. It also models
5 Patent restrictions on products relevant to health do of course entail availability
f  patented commodities only at prices well above the marginal cost of production
nd distribution. With few exceptions, however, patents are unimportant barriers
or access to products capable of inﬂuencing major mortality decline.527 68 71 85
deviation in parentheses below.
some possible determinants of why  the rate of technical progress
varies.6 We  view this exploration of potential determinants as
suggestive and far from deﬁnitive. That said, a number of factors do
appear robustly related to the (very large) cross-country variation
of technical progress in mortality decline.7
We  now present models to incorporate our desired parameter
heterogeneity, then show diagnostic results to establish the impor-
tance of doing so before moving on to our main substantive results.
3.1. Models
Standard econometric analyses of the determinants of cross-
country variation in health outcomes consist of multivariate
cross-sectional (see Filmer and Pritchett, 1999) or panel regres-
sion models (Pritchett and Summers, 1996).8 Since our interest is
in investigating the effect of technical progress on health outcomes
over time, our focus will be on panel models. Consider, then, the
following model of the determinants of the natural logarithm of
under-5 mortality:
ln 5q0it = ˇ0 + ˇ1TIME + ˇ2 ln GDPPCit + ˇ3EDFEMALEit6 Fuchs (1980) observed some time ago that different groups of countries differ in
how  their mortality changes relate both to income change and to technical progress.
This paper can be viewed as drawing out the consequences of Fuchs’s observation
at  the level of countries rather than groups of countries.
7 In related work we  have undertaken a parallel analysis of the determinants
of  country-speciﬁc variation in the rate of change of total factor productivity for
explaining differences in economic growth rates across countries (Jamison et al.,
2005). This speciﬁcation is also used in Jamison et al. (2007).
8 In a paper dealing with infant mortality decline in Sweden, the UK and the US,
Bishai (1995) has developed a cointegration approach for dealing with the long time
series available for those countries.
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xtension is to allow the intercept (ˇ0) to vary across countries,
eading to:
n 5q0it = ˇ0i + ˇ1TIME + ˇ2 ln GDPPCit + ˇ3EDFEMALEit
+ ˇ4 ln DOCSPCit + ıit, (2)
here, ˇ0i is a country-speciﬁc intercept and ıit is a random, i.i.d.,
ormally distributed disturbance. Neither (1) nor (2) allow for het-
rogeneity in the variable coefﬁcients, and assume in particular that
he (conditional) trend change in the health outcome over time (ˇ1)
s the same in all countries.
As we have explained, there is little reason to assume ex ante
hat countries are identical in their abilities to avail themselves of
etter knowledge and improved techniques for reducing mortality.
uppose that instead of Eq. (2), the true model is:
n 5q0it = ˇ0i + ˇ1iTIME + ˇ2 ln GDPPCit + ˇ3EDFEMALEit
+ ˇ4 ln DOCSPCit + it, (3)
here, ˇ1i is a country-speciﬁc time trend and it is a random, i.i.d.,
ormally distributed disturbance. If so, important problems arise
rom imposing Eq. (2) to estimate a relationship that in reality fol-
ows Eq. (3). If the true model is Eq. (3), then the error term in Eq.
2) can be rewritten as:
it =
(
ˇ1i − ˇ1
)
TIME + it (4)
In other words, the error term in Eq. (2) will both be autocorre-
ated and correlated with the regressors (because of the presence of
he time trend). This creates the risk of biased estimates of the true
oefﬁcients, which, we argue below, has in fact occurred in previ-
us work ﬁnding income to be a strong determinant of mortality. In
ddition, using Eq. (2) to estimate Eq. (3) leaves us ignorant about
ross-country variation in technical progress over time.
How serious is this risk? Econometric theory shows that in the
resence of serially correlated variables (those that change gradu-
lly over time, which the determinants of mortality do) imposing
oefﬁcient homogeneity leads to systematically biased estimates.9
everal empirical studies in other areas suggest the problem can
e quantitatively signiﬁcant.10 We  propose that such bias afﬂicts
he extant literature on cross-national determinants of health out-
omes, and that it is necessary to allow for coefﬁcient heterogeneity
hen estimating the strength of these determinants.
In our estimations below, we extend Eq. (3) with the following
peciﬁcations for ˇ0i and ˇ1i:
0i = 00 + 0i (5a)
1i = 10 + 1i (5b)
These equations decompose the intercept and the time trend
n the main equation into a country-invariant and a country-
peciﬁc component. The country-speciﬁc components 0i and 1i
re assumed to be normally distributed, zero-mean random vari-
bles which are independent of the unexplained error term in the
verall equation (formally Cov (0i, ε0i) = 0 and Cov (1i, ε1i) = 0).
his simple speciﬁcation preserves the standard assumption of a
9 Robertson and Symons (1992) constructed dynamic panels with a serially cor-
elated regressor (assumed to be the true determinant of the dependent variable)
nd a lagged dependent variable (with no causal effect). If the regressor is a random
alk, the coefﬁcient on the lagged variable is biased upwards and the coefﬁcient on
he true determinant is biased downwards when coefﬁcient homogeneity is erro-
eously imposed. Pesaran and Smith (1995) found that incorrectly imposing slope
omogeneity yields inconsistent estimates of the true average slopes in ﬁxed or
andom effects panel regressions with serially correlated regressors.
10 Lee et al. (1997, 1998) showed that the slow convergence of per capita incomes
etween countries observed in economic growth research is exaggerated by assum-
ng an identical rate of technology growth across countries. Economics 48 (2016) 16–25 19
common health production function across countries except for
country-speciﬁc level shifts or time trends. With the error structure
given in Eqs. (5a) and (5b), it is equivalent to a hierarchical linear
model, which can be written in the following single-equation form:
ln 5q0it = 00 + 10TIME + ˇ2 ln GDPPCit + ˇ3EDFEMALEit
+ ˇ4 ln DOCSPCit + (0i + 1iTIMEt + εit) (6)
Below, we use a restricted maximum-likelihood algorithm to
estimate this model, and report results for more complex error
structures in the Web  appendix.
To assess how much of the cross-country coefﬁcient variation
can be explained by country characteristics we also explore alter-
native level-2 models which include the time-invariant variables
mentioned above as possible determinants of the country-speciﬁc
coefﬁcients in the level-1 model:
ˇ0i = 00 + 01TROPICSi + 02COASTALi + 03IMMUNIZATIONi
+ 04OPENNESSi + 0i (7a)
ˇ1i = 10 + 11TROPICSi + 12COASTALi + 13IMMUNIZATIONi
+ 14OPENNESSi + 1i (7b)
In the diagnostic results reported in the next section, we esti-
mate a simple version of Eqs. (7a) and (7b) that only includes
immunization coverage as a level-2 predictor. Later we present full
results.
3.2. Diagnostic results
Table 2 reports our estimation of Eqs. (1), (2), (6), and (7). The
generic model in column A imposes a common intercept and time
trend on all countries. The model in column B allows for a vary-
ing country-speciﬁc intercept shift but retains the constraint of a
common time slope. This benchmark model is very similar to the
speciﬁcation in Pritchett and Summers (1996).11 As we relax the
homogeneity assumption in columns C and D we ﬁrst let the time
trend vary as well and then include a level-2 determinant (immu-
nization) for both the intercept and the time trend. In order to
estimate the different models, we use the restricted maximum-
likelihood procedure known as hierarchical linear modeling or
HLM.12
The estimates in column B are very close to those found in the
previous literature, e.g., Pritchett and Summers (1996). In partic-
ular, the estimated −0.26 elasticity of 5q0 with respect to income
is close to their estimates between −0.2 and −0.4 and implies that
a 10% increase in real per capita GDP would reduce 5q0 by 2.6%.
Given economic growth rates in the 1970–2000 period, this would
mean GDP growth and technical progress in mortality reduction
contributed about the same to observed 5q0 declines.
As discussed above, however, the complex error structure makes
least squares methods used in the earlier literature biased. The
11 One difference is that they model the intercept shift as a ﬁxed effect; we model
it  as a random or variable effect. We discuss this modeling choice in some detail
below; the difference it makes to the other coefﬁcient estimates is negligible.
12 For the econometric details of the estimation method, see Bryk and Raudenbusch
(1992) and Kreft and De Leeuw (1998). We estimate the models in R (version 2.10.0)
using restricted maximum likelihood estimation with the command lmer from the
package lme4 (Bates et al., 2008) for the hierarchical models, and with the com-
mand lm from the base package for the pooled, ﬁxed effects, and difference models
reported in the Web  appendix.
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Table 2
Determinants of under-5 mortality: diagnostic results.
Model A B C D
Equation (1) (2) (6) (6,7)
Coefﬁcient estimates
Intercept (constant across countries) 8.452 . . .
(−44.05)
TIME  (constant across countries) −0.013 −0.021 . .
(−6.33) (−13.88)
lnGDPPC −0.345 −0.257 −0.122 −0.095
(−11.08)  (−8.06) (−4.26) (3.33)
EDFEMALE −0.121 −0.074 −0.036 −0.027
(−11.47) (−6.87) (−3.49) (−2.60)
lnDOCSPC −0.101 −0.105 −0.112 −0.123
(−4.04)  (−4.05) (−6.54) (7.37)
Level-2 model: determinants of TIME coefﬁcient
TIME (constant component)—10 . −0.027 −0.001
(−13.63) (0.25)
SD  of variance component of TIME–SD( 1i) 0.015 0.013
DTP3-86 −0.40
(5.49)
Level-2 Model: Determinants of the Intercept
Intercept (constant component)—100 8.135 7.388 7.049
(−30.05) (24.92) (26.60)
SD  of variance component of Intercept–SD( 0i) 0.360 0.517 0.53
DTP3-86 −0.38
(1.21)
Estimation Statistics
N 573 573 573 573
Countries 95 95 95 95
RMSE  0.425 0.152 0.06 0.06
R2 0.799 0.974 0.996 0.996
AIC  658 −58 −554 −559
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tote: Robust t-statistics in parentheses under the point estimates. The dependent v
eason for this is that models without a randomly varying time
lope (columns A and B) are constrained versions of the equivalent
odel that allows this variation. For example, Eq. (2) (estimated
n column B) is a restricted version of Eq. (6) (column C) which
onstrains the variance of the country-speciﬁc slope and its covari-
nce with the intercept to be zero. Statistical tests of whether this
estriction is valid overwhelmingly indicate that it is not.13
What is of interest is how the coefﬁcient on income changes
hen the assumption of identical technical progress across
ountries is relaxed, as the data indicate it should be. Column
 shows that the income effect is then much smaller than what
as been found in cross-country regressions. A 5q0-elasticity with
espect to income of −0.122 implies that a doubling of GDP, ceteris
aribus, is associated with a fall in the under-5 mortality rate of
nly about 8.1% (e−0.122(ln(2)) ≈ 0.919). This suggests that for reduc-
ng under-5 mortality, purely growth-oriented policies may  not be
articularly effective. Instead it may  be much more important to
nderstand the cross-country differences in adoption of low-cost,
ife-saving technologies.14 Easterly (1999) found a broadly similar
13 The bottom row of Table 2 gives our preferred indicator, the Akaike information
riterion (AIC). The AIC is calculated as AIC = 2k − 2 ln L, where k is the number of
arameters in the model and L is the maximized value of the likelihood function
so the AIC penalizes a model that includes more parameters to avoid overﬁtting).
 smaller (or more negative) AIC then reﬂects a speciﬁcation that is more likely
o  be the best representation of the true model. On this criterion, the models with
ountry-speciﬁc technical progress over time are vastly preferable to the more con-
trained models. The difference between two models’ AIC is their logged likelihood
atio adjusted for the different number of parameters estimated, so this number can
e  used for a likelihood ratio test between two  chosen models. Between models B
nd C (C estimates two more parameters than B) the test statistics (554 – 58 + 2) = 498
s  well above critical values at conventional signiﬁcance thresholds. Again, this sug-
ests it is invalid to constrain the time trend to be the same for all countries.
14 Much empirical evidence points, however, to a strong within-country correla-
ion of income and health (e.g., Wagstaff et al., 2004). Deaton (2001) pointed to onee is logged 5q0. Unbalanced panel using up to 7 time periods for each country.
pattern of ﬁndings on the importance of income for other social
indicators. (In Web  appendix C, we show that this low estimate of
the income elasticity under heterogeneous time-slopes is robust to
a number of other estimation choices.)
The fact that the income coefﬁcient falls when country-speciﬁc
time trends are allowed has an important substantive interpre-
tation. It means, on the one hand, that much of the strong effect
of income on mortality outcomes found in previous work sim-
ply captures the pattern that countries that have grown rich
fast have also cut mortality fast. On the other hand, it means
that there is little effect of changes in incomes around long-
term trends—accelerations, slowdowns and ﬂuctuations in GDP
has little bearing on mortality outcomes. That supports our gen-
eral conclusion that health depends more on the accumulation of
technology and know-how over time than on the availability of
resources.
To summarize: There are no ex ante reasons to believe that rates
of technical progress are the same for all countries. Econometric
theory shows that imposing slope homogeneity when slopes in
reality are country-speciﬁc leads to inconsistent estimates with
conventional methods when the variables are serially correlated.
And a cursory examination of data on under-5 mortality rates and
their determinants reveals that this inconsistency may lead to a
serious misunderstanding of the relationships between per capita
income, technical progress and health outcomes. In the next sec-
tion, we employ a varying coefﬁcients model to take seriously the
interpretation, which is that an individual’s health may  be affected by her standing
relative to a salient reference group (rather than her income level per se), which
in  this case would be the country. This is logically consistent with a much weaker
relationship between income and health across countries or in a single country over
time.
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ossibility of country-speciﬁc rates of technical progress, and inves-
igate the determinants of these country differences.
. Determinants of under-5 mortality
The previous section provided an overview of the strong intu-
tive, theoretical and empirical reasons for relaxing the assumption
f time trend homogeneity in the econometric analysis of cross-
ountry variations in health outcomes.15 We  now proceed to
nalyze more detailed models of the determinants of child mor-
ality rates when that assumption is relaxed. These models are in
ther respects similar to earlier approaches.
.1. Selection of models
We  make three important modeling choices, relating to (a) the
unctional form of our estimating equations; (b) the choice to model
eterogeneous coefﬁcients as (conditionally) randomly distributed
ather than a dummy  variable approach; and (c) the choice to retain
he assumption of homogeneous coefﬁcients for variables other
han time. We  discuss each of these in turn.
.1.1. Functional form of the estimating equation
Using the log of under-5 mortality rates on the left-hand side
instead of raw levels) allows comparison of our results with
xtant ﬁndings, and has a theoretical and practical advantage that
he coefﬁcients are (conditional) elasticities or semi-elasticities of
q0 with respect to a predictor of interest. Estimating elasticities
eﬂects the plausible idea that it should take more resources to
educe 5q0 by a given absolute amount the lower is its current
evel.
.1.2. Varying coefﬁcients or indicator variables
For clarity we follow the vocabulary described in Gelman
nd Hill (2007). When country speciﬁc coefﬁcients are esti-
ated using a hierarchical linear model as in Eq. (6) we  describe
oefﬁcients as varying and we describe our models as varying effect
odels.
A varying coefﬁcients approach has two main advantages over
xed effects. First, in these short time series (a maximum of seven
ime periods per country) estimating coefﬁcients on two  interac-
ion terms per country (for the intercept and for the time slope)
ould use twice as many degrees of freedom as we have countries.
econd, we are interested not just in allowing the intercept and
he time slope to vary across countries, but also to model this vari-
tion as a function of time-invariant country characteristics. This
e cannot do directly with an indicator variable approach, since
he coefﬁcient on an indicator interacted with time will pick up all
he time-invariant cross-country variation.
.1.3. Remaining coefﬁcient homogeneity
If we think that coefﬁcients vary across countries, why do we
ontent ourselves with relaxing the homogeneity assumption for
he time coefﬁcient, without allowing country-speciﬁc estimates
or the other determinants? We  do report results from such esti-
ations in Web  appendix B and ﬁnd our main results are robust
llowing country-speciﬁc estimates for income, female education,
15 Oeppen (2006) independently applied models closely related to ours to assess
for  a smaller group of countries over a much longer time frame) country-speciﬁc
lasticities of mortality with respect to income levels and country-speciﬁc rates of
echnical progress (although he uses different terminology). Economics 48 (2016) 16–25 21
or doctors per capita. However, as a ﬁrst step towards relaxing the
assumption of slope homogeneity, country-speciﬁc rates of tech-
nical progress is a natural and parsimonious approach, and it is
conceptually very close to the conventional practice of letting inter-
cepts vary. The standard speciﬁcation, with a log transformation
of q50 and country level effects, implies that countries differ by a
ﬁxed multiplicative productivity shift (additive in the log form) in
how well they make use of a given set of inputs to achieve mortal-
ity outcomes. This time trend simply means that this productivity
shift changes over time. Our approach, then, is to let productiv-
ity levels, assumed to differ between countries in the literature,
also change at different speeds. This is hardly a great conceptual
leap. We  therefore think it is useful to begin by concentrating on
this conceptually small but empirically consequential modiﬁcation
to current practice. Moreover, Web  appendix B shows that allow-
ing the time trend to vary has much greater implications for the
estimated effects of the other variables (and contributes more to
model ﬁt) than does country-speciﬁc heterogeneity in the other
coefﬁcients.
4.2. Determinants of the varying effects
The estimates for our benchmark model are reported in Table 2
(model C). Other things equal, the estimated time trend means
that under-5 mortality rate decreases by 2.7% per year on aver-
age across countries. This impact of technical progress dwarfs the
effects of the other variables. The elasticity of 5q0 with respect to
income is −0.122. A 10% (or $328 at the sample mean) increase
in income is associated with a 1.2% fall in under-5 mortality, or
about 1.1 fewer deaths per thousand births at the sample mean.
We estimate that one additional year of female education is asso-
ciated with about a 3.6% fall in under-5 mortality (or about 3.1
fewer deaths per thousand at the sample mean). A 10% increase in
the number of physicians per capita would reduce under-5 mor-
tality by 1.1%. These effects are all small compared to technical
progress.
Table 3 reports models that introduce the geographical and
public health variables to see if they contribute to explaining cross-
country differences. Model E includes them in the level-2 model for
the intercept. A completely tropical country (TROPICS = 1) has, on
average, a 31% higher under-5 mortality rate than a non-tropical
one. A country whose entire population lies within 100 km of the
coast or a navigable river (COASTAL = 1) has, on average, a 50%
lower under-5 mortality rate than a completely landlocked one.
A country whose entire population had received DPT3 vaccina-
tion has, on average, a 64% lower under-5 mortality rate than one
with no DPT3 penetration. These results are, of course, hard to
interpret conclusively. They could reﬂect the different disease envi-
ronments or the relatively low productivity of tropical agriculture.
Or there could be omitted variable bias if, for example, tropical
countries have less developed health care infrastructure for reasons
not related to the climate itself. As for immunization rates, they are
correlated with many measures of development, so we discuss in
Web  appendix C whether other development variables are more
appropriate.
4.3. Determinants of technical progress
We see in columns F–I of Table 3 that the coefﬁcients in the
level-2 model of the time slope are both statistically signiﬁcant
and quantitatively important. Model F estimates, for example,
imply that an average temperate, coastal country (TROPICS = 0;
COASTAL = 1) reduces its 5q0 by 4.4% per year, about three times
as fast as an average tropical and landlocked country (TROPICS = 1;
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Table 3
Determinants of log under-5 mortality: the effects of income, education, physician coverage, geography, and technical progress.
E F G H I J
Level-1 model
Mean intercept effect 6.452 6.377 6.389 6.447 6.463 6.442
Mean  TIME slope −0.028 −0.029 −0.029 −0.028 −0.026 −0.027
lnGDPPC −0.113 −0.086 −0.106 −0.106 −0.107 −0.107
(−3.94) (−3.02) (−3.52) (−3.53) (−3.55) (−3.64)
EDFEMALE −0.032 −0.03 −0.016 −0.016 −0.129 0.028
(−3.09) (−3) (−1.58) (−1.58) (−1.25) (2.21)
lnDOCSPC −0.11  −0.114 −0.077 −0.077 −0.080 −0.087
(−6.47) (−6.82) (−4.45) (−4.45) (−4.64) (−5.19)
EDFEMALE × OPENNESS . . . . . −0.185
(−5.44)
Level-2  model: determinants of TIME coefﬁcient
TIME (constant component)–10 −0.028 −0.026 −0.025 −0.025 −0.014 −0.018
(−13.89) (−8.7) (−8.56) (−8.68) (−2.52) (−3.14)
SD  of variance component of TIME–SD( 1i) 0.015 0.011 0.011 0.012 0.010 0.011
TROPICS .  0.012 0.013 0.013 0.010 0.010
(4.24) (4.76) (4.78) (3.48) (3.20)
COASTAL .  −0.018 −0.013 −0.013 −0.011 −0.011
(−4.94) (−3.75) (−3.79) (−3.12) (−2.84)
OPENNESS .  . −0.019 −0.02 −0.018 0.011
(−4.09) (−5.36) (−3.98) (1.50)
DPT3-86 .  . . . −0.017 −0.019
(−2.41) (−2.56)
Level-2  model: determinants of intercept
Intercept (constant component)–00 7.447 7.23 7.269 7.009 7.009 6.889
(28.46) (27.26) (26.5) (23.9) (22.39) (22.37)
SD  of variance component of intercept–SD( 0i) 0.517 0.452 0.454 0.450 0.450 0.448
TROPICS 0.268 −0.009 0.067 0.137 0.137 0.135
(2.69) (−0.07) (0.55) (1.11) (1.11) (1.10)
COASTAL −0.695 −0.273 −0.333 −0.393 −0.393 −0.375
(−6.1) (−1.96) (−2.22) (−2.61) (−2.61) (−2.50)
OPENNESS .  . −0.047 −0.0721 −0.072 0.426
(−0.25) (−0.38) (−0.38) (2.03)
DPT3-86 −1.014 −1.024 . −0.824 −0.824 −0.745
(−3.92) (−3.99) (−2.687) (−2.69) (−2.44)
Estimation statistics
N 573 573 527 527 527 527
Countries 95 95 87 87 87 87
RMSE  0.06 0.06 0.057 0.057 0.057 0.055
R2 0.996 0.996 0.996 0.996 0.996 0.997
AIC  −562 −577 −581 −584 −576 −597
N  5q0. 
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mote: Robust t-statistic in parenthesis under estimate, dependent variable is logged
OASTAL = 0), whose rate is 1.4% per year. Models G and H show that
conomic openness also contributes greatly to mortality reduction:
he economically most open countries (OPENNESS = 1) on average
ave a rate of technical progress in 5q0 outcomes that is around
 percentage points per year faster than economically closed, but
therwise similar countries. In 25 years, this substantial differen-
ial accumulates to an additional 39% reduction in 5q0. Countries
hat are not open to the world economic system miss out not only
n gains from trade and specialization in production, but also on
nformation ﬂows and the beneﬁts of technological diffusion in
ealth.16
Finally, in model I we also included DPT3-86 as a determi-
ant of the TIME coefﬁcient, and found that countries with greater
accine coverage, too, have signiﬁcantly faster mortality declines,
ndependently of income, educational attainment, or doctors per
apita. Speciﬁcally, a 10 percentage point increase in 1986 vaccine
16 An alternative view of the important of openness is that it inﬂuences the gains
o  education rather than technical progress over time. We  test this in model J, in
hich the education variable is interacted with openness in the level-1 equation.
he results bear out the intuition: the effect of openness on the time slope becomes
nsigniﬁcant, while the level-1 coefﬁcient on the interacted variable is large and sig-
iﬁcant. Consistent with a model of economics of education going back to Schultz
1961), our model ﬁnds that the positive effect of education is greater in environ-
ents having greater economic openness.All models assume heterogeneity both in level and in time.
coverage is associated with 0.19 percentage point faster annual rate
of mortality decline. Our interpretation is that DPT3 coverage prox-
ies for a health system’s orientation toward early introduction of a
range of high priority interventions.
Even after adding these country characteristics to explain
country-speciﬁc technical progress, large cross-country variations
in the time slope remain, captured by the random term 1i of
Eq. (6). For many countries, this unexplained part of the country-
speciﬁc time trend is of comparable magnitude to the effects of
the geographic, openness and vaccination variables. The standard
deviation of 1i is between 0.010 and 0.015, or more than one per-
centage point per year in the rate of technical progress. That is
substantial given an average overall time trend (calculated with
the determinants at their mean values) of 2.6–2.9% per year. The
importance of a 1.5 percentage point better (more negative) rate
of technical progress is illustrated by a simple calculation: After
25 years, that one-standard deviation improvement makes 5q0
a full 31% less than what it would be in an otherwise identical
country.
5. Decomposing the decline in 5q0We  highlight three main empirical ﬁndings from the previous
sections. First, the raw annual rate of mortality decline varies enor-
mously across countries, with a range of −0.5 to 8% per year around
D.T. Jamison et al. / Journal of Health
Fig. 2. Factors accounting for decline in under-5 mortality, all low- and middle-
income countries, 1970–2000. Note: Under-5 mortality (5q0) averaged across all
countries declined from 143 per thousand in 1970 to 62 per thousand in 2000. The
average country-speciﬁc rate of decline was 3.4% per year. This graph shows the
contribution of selected policy-elated determinants of this decline. Decline associ-
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Global collective efforts have played increasingly substantialted with technical progress is broken down into geographic, DPT3 immunization
overage, and unexplained country effects in Web  appendix D.
 mean of about 3.4% per year. Second, when rates of improve-
ent over time, or technical progress in mortality reduction, are
odeled explicitly as varying across countries, the estimated effect
f income on 5q0 outcomes is substantially reduced, but this is less
rue for the impact of education and doctor coverage. Third, there
re clear correlations between technical progress and geographic
haracteristics, as well as between technical progress and economic
nd health system variables.
In this section we add one further insight. Just as the eco-
omic growth literature reports decompositions of growth into
lements associated with increased levels of inputs and produc-
ivity growth, so, too, 5q0 declines can be decomposed into the
ontribution of different factors. For each country and for the sam-
le as a whole we identify the estimated contributions to 5q0
ecline due to each of four components: the decline due to changes
n income levels, education levels, doctor coverage, and technical
rogress.
5q0 in low- and middle-income countries declined dramatically
n the period 1970–2000, from 143 per thousand to 63. The average
er capita income increased by 78% (from $2300 to $4100) and
he average length of women’s education increased from 3.4 to 7.5
ears. Doctor coverage trebled from 4.4 to 13.4 doctors per 1000
eople. How much did each of these factors contribute to the total
q0 decline? And how much of the decline remains unaccounted for
y these factors and, by convention, can be attributed to technical
rogress? The answers to these questions are country-speciﬁc both
ecause the input changes are country-speciﬁc and because the
alculated rate of technical progress is.
We  use the estimates from the fullest model, reported in column
 of Table 3, for the decomposition. For each country, we measure
he change in each of the inputs, apply the estimated effects of these
nputs, and add the total country-speciﬁc technical progress over
he period (30ˇ1i) to calculate a predicted change in the log of 5q0.
he decomposition then divides the predicted effect on 5q0 of each
actor by the total predicted 5q0 decline. At sample averages we
ttribute 3% of the 5q0 decline to increases in per capita income,
% to improvements in female education, 9% to the increased num-
er of physicians and 80% to technical progress (Fig. 2). While Economics 48 (2016) 16–25 23
technical progress explains 80% of mortality improvements across
countries, its importance varies widely across countries—from 54%
in China (whose rate of 5q0 decline is 3.5% per year) to 82% in
India (whose pace is 2.9%) to 83% in Mexico (whose pace is 4.8%).
This wide variation in realized technical progress provides most of
the answer to the question posed in the title of this paper: “Why
has under-5 mortality declined at such different rates in differ-
ent countries?” Web  appendix Table D2 reports decompositions
by country.
6. Conclusion
The 20th century witnessed huge and unprecedented declines
in mortality rates at all ages and in most parts of the world. Under-
standing the sources of these changes is important not only for
understanding one of the deﬁning events of world history but, also,
to devise policies to address the needs of the quarter of the world’s
population whose mortality rates remain far higher than those of
the rest of humanity.
Several approaches shed light on the sources of mortality
decline. Epidemiologists and demographers have carefully tracked
speciﬁc communities for many years to assess what causes mor-
tality decline, and for what reasons. An interesting example of
this approach found, in rural Senegal, that much of the rapid
mortality decline there could be traced to the introduction of
interventions addressing speciﬁc conditions (Pison et al., 1993).
Another approach is historical. Easterlin (1996, 1999), for example,
examined the interplay of economic growth, urbanization and mor-
tality in 19th and 20th century Europe. He found little correlation
between the timing of periods of economic growth and mortal-
ity decline and concluded that income growth in the 19th century
probably had a real but modest impact on reducing mortality
through its inﬂuence on food availability and environmental condi-
tions. Fogel (1997) has also stressed the importance of increases in
food availability during this period. These positive factors were par-
tially offset by increased infectious disease transmission resulting
from urbanization. Easterlin concludes that 20th century mortality
decline, which was much more rapid than that of the 19th century,
had its origin in technical progress, and Powles (2001) has pointed
to the importance and nature of the institutional changes required
to translate technical change and economic improvements into
mortality reduction.
Increasingly good time series data have become available
on country-speciﬁc demographic and economic conditions for
the period from around 1960. These data have allowed statisti-
cal assessment of relations among income, education, technical
progress and mortality, a line of work initiated by Preston (1975,
1980). This paper adds to that literature by continuing to explore
of the role of geographical variables (work begun by Bloom et al.,
1999) and, more importantly, by allowing for heterogeneity across
countries in the rate of technical progress in mortality decline.
We ﬁnd that there is high variation across countries in the rate
of improvement over time and that taking account of that varia-
tion substantially reduces the estimated effect of income on health.
Even in a period of rapid economic growth income changes can
account for only a modest fraction of the changes in under-5 mor-
tality in most countries. Variations in technical progress and (to a
lesser extent) educational improvements are far more important
in explaining why  under-5 mortality has declined so much, and at
such different rates in different countries.roles in the period covered by this study. Most of these lie in the
public sector, including well-funded programs to expand immu-
nization coverage, to treat childhood diarrhea and pneumonia, and
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o prevent and treat malaria. Best practices spread, but unevenly
ecause of both variations across countries in funding received and
ariation in the learning afforded by participation in the technical
overnance of the programs. Variable participation in private sec-
or clinical trials may  also have contributed to differential uptake
f innovation. We  would speculate that the World Health Organi-
ation as well as development assistance agencies played a critical
ole in accelerating diffusion of life-saving innovations around the
orld. At the same time variable participation in WHO’s work and
ptake of its recommendations may  have contributed to high vari-
nce in progress around a high mean.
Drawing on Mosk and Johansson’s (1986) assessment of the
nterplay between income and mortality in Japan, it may  be an
nstructive simpliﬁcation to categorize mortality history into 3 or
 epochs. Epoch I, extending up to the late 18th century, was a
eriod of ups and downs in mortality rates unaccompanied by any
pward trend. Epoch II, in the 19th century, witnessed slow but
eal mortality reductions among the North Atlantic countries that
esulted from improved diets and other consequences of income
rowth, but that were partially counterbalanced by the adverse
ffects of urbanization. Epoch III, in the 20th century, was  a period
f very rapid mortality decline in much of the world that was
ased on the generation and diffusion of inexpensively applied new
nd existing knowledge and speciﬁc technologies embodying that
nowledge. The Lancet Commission on Investing in Health (Jamison
t al., 2013) pointed to an Epoch IV, in the ﬁrst third of the 21st
entury, involving convergence of all countries’ mortality rates to
he levels technology has now made possible even at low levels of
ncome.
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